Skip to main content
Top
Published in:

01-10-2019 | Chronic Lymphocytic Leukemia | Case report

Ibrutinib

Hyperleukocytosis and leukostasis: case report

Published in: Reactions Weekly | Issue 1/2019

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Footnotes
1
Reporter country not stated. Author communication details not available.
 
Literature
go back to reference Ibrahim S, et al. IBRUTINIB-INDUCED HYPERLEUKOCYTOSIS AND LEUKOSTASIS IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA. Chest 156 (Suppl.): A2149-A2150 (plus poster), No. 4, Oct 2019. Available from: URL: https://journal.chestnet.org/issues [abstract] - Unknown Ibrahim S, et al. IBRUTINIB-INDUCED HYPERLEUKOCYTOSIS AND LEUKOSTASIS IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA. Chest 156 (Suppl.): A2149-A2150 (plus poster), No. 4, Oct 2019. Available from: URL: https://​journal.​chestnet.​org/​issues [abstract] - Unknown
Metadata
Title
Ibrutinib
Hyperleukocytosis and leukostasis: case report
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2019
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-69945-6